Sierra oncology, inc. (SRRA)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Dec'14
ASSETS
CURRENT ASSETS:
Cash and cash equivalents

133,534

147,528

67,694

78,831

90,908

106,046

116,128

125,425

133,829

100,348

107,824

116,699

125,025

109,007

122,682

130,550

140,871

150,180

157,308

15,800

29,154

Short-term investments (Note 4)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,028

10,010

Prepaid expenses and other current assets

1,936

2,369

3,118

3,761

3,699

2,706

3,203

2,423

2,159

1,377

1,745

566

775

1,343

1,822

543

1,746

1,673

1,280

782

561

Total current assets

135,470

149,897

70,812

82,592

94,607

108,752

119,331

127,848

135,988

101,725

109,569

117,265

125,800

110,350

124,504

131,093

142,617

151,853

158,588

26,610

39,725

Property and equipment, net

112

113

137

134

150

168

125

121

144

154

183

256

347

400

357

401

623

566

565

397

214

Operating lease right-of-use asset

547

589

630

671

716

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

662

729

738

778

622

549

596

578

303

319

313

312

203

223

205

200

196

349

203

3,256

626

TOTAL ASSETS

136,791

151,328

72,317

84,175

96,095

109,469

120,052

128,547

136,435

102,198

110,065

117,833

126,350

110,973

125,066

131,694

143,436

152,768

159,356

30,263

40,565

LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accrued and other liabilities

5,640

7,170

6,738

7,064

6,619

8,812

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued liabilities

-

-

-

-

-

-

7,168

6,774

4,898

6,133

5,832

5,002

4,122

5,121

13,958

6,190

5,342

7,016

2,913

2,304

1,473

Accounts payable

1,357

1,019

1,304

1,203

619

1,287

962

1,122

740

1,339

458

521

1,100

2,604

174

734

1,779

358

849

1,925

622

Warrant liabilities

-

45,935

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Securities issuance obligation

-

10,485

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of term loan

-

-

1,171

668

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7

23

38

-

-

Total current liabilities

6,997

64,609

9,213

8,935

7,238

10,099

8,130

7,896

5,638

7,472

6,290

5,523

5,222

7,725

14,132

6,924

7,128

7,397

3,800

4,229

2,095

Operating lease liability

298

374

415

466

503

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Term loan

-

-

3,841

4,303

4,763

4,891

4,856

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock warrant liabilities (Note 10)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,641

1,810

Other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

113

100

TOTAL LIABILITIES

7,295

64,983

13,469

13,704

12,504

14,990

12,986

7,896

5,638

7,472

6,290

5,523

5,222

7,725

14,132

6,924

7,128

7,397

3,800

14,983

4,005

Commitments and Contingencies (Note 8)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

Convertible preferred stock value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

297,652

144,375

STOCKHOLDERS' EQUITY:
Preferred stock, $0.001 par value; 10,000,000 shares authorized as of March 31, 2020 and December 31, 2019; nil shares issued and outstanding as of March 31, 2020 and 103,000 shares Series A convertible voting preferred stock issued and outstanding as of December 31, 2019

-

1

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

-

0

Common stock, $0.001 par value; 500,000,000 shares authorized as of March 31, 2020 and December 31, 2019; 10,395,732 and 1,867,176 shares issued and outstanding as of March 31, 2020 and December 31, 2019

10

74

74

74

74

74

74

74

74

52

52

52

52

30

30

30

30

30

30

2

2

Additional paid-in capital

927,085

851,957

776,999

775,719

773,961

771,817

770,121

768,139

766,325

718,751

717,201

715,741

714,230

685,272

683,710

682,337

681,003

679,528

678,255

0

-

Accumulated other comprehensive loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-10

Accumulated deficit

-797,599

-765,687

-718,225

-705,322

-690,444

-677,412

-663,129

-647,562

-635,602

-624,077

-613,478

-603,483

-593,154

-582,054

-572,806

-557,597

-544,725

-534,187

-522,729

-282,374

-107,807

TOTAL STOCKHOLDERS' EQUITY

129,496

86,345

58,848

70,471

83,591

94,479

107,066

120,651

130,797

94,726

103,775

112,310

121,128

103,248

110,934

124,770

136,308

145,371

155,556

-282,372

-107,815

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

136,791

151,328

72,317

84,175

96,095

109,469

120,052

128,547

136,435

102,198

110,065

117,833

126,350

110,973

125,066

131,694

143,436

152,768

159,356

30,263

40,565